BML Investment Partners, L.P. - 19 May 2025 SCHEDULE 13D Report for Adverum Biotechnologies, Inc. Common Stock, par value $0.0001 per share (ADVM)

Filing Manager: BML Investment Partners, L.P.
Reporting Manager: Leonard Braden Michael
Security: Adverum Biotechnologies, Inc. Common Stock, par value $0.0001 per share
Symbol: ADVM
Shares outstanding: 20,829,013 shares
Disclosed Ownership: 3,249,326 shares
Ownership: 15.6%
Form type: SCHEDULE 13D
Filing time: 20 May 2025, 08:27:28 UTC
Date of event: 19 May 2025
Previous filing: 06 May 2025
Next filing: 10 Nov 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BML Investment Partners, L.P.	14.6%	3,057,526	0	3,057,526	Braden M Leonard	Braden M Leonard - Managing Member of BML Capital Management, LLC	0001373604
Leonard Braden Michael	15.6%	3,249,326	191,800	3,057,526	Braden M Leonard	Leonard Braden Michael	0001373603